nebivolol

(redirected from Bystolic)
Also found in: Thesaurus, Medical.
Related to Bystolic: Nebivolol, Crestor
Translations

nebivolol

n nebivolol m
References in periodicals archive ?
Nebivolol is approved and marketed in the US as BYSTOLIC for the treatment of hypertension to lower blood pressure.
Nebivolol, which is approved for treating hypertension, is marketed by Forest as Bystolic.
The agency's outside panel of heart specialists voted 8-0 against approving Bystolic to prevent death or hospitalization caused by heart failure, according to an FDA spokeswoman.
revenue related to the sale of the company's rights to Bystolic.
Comment: In three monotherapy trials of more than 2,000 patients, and one combination therapy trial of almost 700 patients, the blood pressure-lowering effects of Bystolic were in the high single digits, which is comparable with other [beta]-blockers, although not to the degree expected with a diuretic or calcium blocker, said Dr.
The FDA has approved Bystolic (nebivolol) for the treatment of high blood pressure.
Civil Development work (Park Plantation, Water Pipe Line etc) at 400 KV S/S Manth (Mathura)coupon for bystolic generic name for bystolic when will bystolic go generic
0% DRUGS COMING OFF PATENT DRUG INDICATION YEAR Zymaxid antibiotic 2016 Aczone acne 2016 TOP SELLING DRUGS 2015 DRUG INDICATION SALES (+/-%) Botox chronic migraine, $656 n/a overactive bladder Restasis dry eye $365 n/a Lumigan ocular hypertension $192 n/a Namenda XR Alzheimer's disease $190 27% Delzicol/Asacol ulcerative colitis $163 3% Bystolic hypertension $169 10% Alphagan/ glaucoma, $139 n/a Combigan ocular hypertension Linzess/ irritable bowel syndrome $131 39% Constella
He also led the organization through the approval and launch of Bystolic for hypertension and Campral for alcohol dependency.
M2 PHARMA-April 3, 2012-Forest Laboratories Inc acquires Bystolic Royalties from Janssen Pharmaceutica NV for USD357m(C)2012 M2 COMMUNICATIONS
In a review posted online, the agency said results from a company study of Bystolic "lack robustness," and don't show a clear advantage for the drug.